Organometallics
Article
47.23 (46.84); H, 4.54 (4.74), N, 3.85 (3.77). 1H NMR (400 MHz, 25
°C, CD2Cl2): δ (ppm) 1.79 (s, 6H, α-CH3), 2.26 (s, 12H, o-CH3),
5.07 (s, 6H, η6-C6H6), 5.66 (s, 1H, β-CH), 7.04−7.08 (m, 2H, Ar p-
CH), 7.21−7.23 (m, 4H, m-CH). 13C{1H} NMR (100 MHz, 25 °C,
CD2Cl2): δ (ppm) 19.3 (s, o-CH3), 23.3 (s, α-CH3), 76.9 (s, η6-C6H6),
103.4 (s, β-CH), 126.8 (s, Ar p-CH), 128.9 (s, Ar m-CH), 132.4 (s, Ar
o-C), 156.8 (s, Ar i-C), 162.9 (s, CN). ESI MS+ (25 °C, CH2Cl2)
(m/z): 575.240 [parent M − Cl−, 100%, calcd 575.201]. FT-IR (25
°C, ATR): ν (cm−1) 3391 (m, br), 3054 (w), 2956 (w), 2919 (m),
1641 (w), 1622 (w), 1590 (w), 1553 (w), 1528 (s), 1465 (w), 1450
(m), 1428 (m), 1392 (vs), 1334 (w), 1264 (w), 1242 (w), 1186 (s),
1172 (w), 1098 (w), 1090 (w), 1024 (w), 978 (w), 907 (w), 852 (s),
843 (m), 817 (w), 798 (w), 773 (m), 767 (vs), 760 (s), 756 (s), 711
(w).
(ppm) −6.65 (s, 1H, Os-H), 1.98 (s, 6H, o-CH3), 2.06 (s, 6H, o-
CH3′), 2.23 (s, 6H, α-CH3), 3.14 (d, 2JHH = 14,8 Hz, 1H, β-CH), 4.44
(d, 2JHH = 14,8 Hz, 1H, β-CH), 4.67 (s, 6H, η6-C6H6), 7.05−7.08 (m,
2H, Ar p-CH), 7.12−7.14 (m, 2H, Ar m-CH), 7.21−7.22 (m, 2H, Ar
m-CH′). 13C{1H} NMR (100 MHz, 25 °C, CD2Cl2): δ (ppm) 18.0 (s,
o-CH3), 18.2 (s, o-CH3′), 23.8 (s, α-CH3), 54.9 (s, β-CH), 79.0 (s, η6-
−
C6H6), 121.2 (q, 1JCF = 321.5 Hz, CF3SO3 ), 127.7 (s, Ar p-CH), 127.9
(s, Ar o-C), 129.0 (s, Ar m-CH), 129.2 (s, Ar m-CH′), 129.5 (s, Ar o-
C′), 153.2 (s, Ar i-C), 177.8 (s, CN). Note: T1 of Os−H is 1.082 s
(as measured by the inversion recovery method). FT-IR (25 °C,
ATR): ν (cm−1) 3067 (vw), 2976 (w), 2922 (w), 2867 (w), 1981 (w,
Os−H), 1633 (vw), 1589 (vw), 1562 (w), 1511 (w), 1469 (w), 1431
(w), 1383 (w), 1469 (w), 1431 (w), 1383 (w), 1346 (w), 1305 (w),
1259 (vs), 1223 (m), 1149 (s), 1095 (w), 1067 (vw), 1030 (s), 910
(w), 859 (w), 825 (m), 771 (m), 753 (w), 715 (w), 637 (s).
Synthesis of [(η6-C6H6)Os{(2,6-Me2-C6H3NCMe)2CH}]OTf (2-
Os). 1-Os (300 mg, 0.49 mmol) and NaOTf (93 mg, 0.54 mmol) were
added to a 50 mL Schlenk tube under a N2 atmosphere. The solids
were dissolved in dried and N2-saturated CH2Cl2 (10 mL) and stirred
overnight. The solution was filtered over Celite under inert conditions
to remove NaCl. The solvent was evaporated, and the crude product
was washed with dried and N2-saturated n-pentane, decanted, and
dried under vacuum to afford 2-Os (312 mg, 88%) as a dark brown
solid. Anal. Found (calcd): C, 46.40 (46.35); H, 4.31 (4.36); N, 3.87
(3.83). ESI MS+ (25 °C, CH2Cl2) (m/z): 575.267 [parent M+, 100%,
Synthesis of [(η6-C6H6)Os(C2H4){(2,6-Me2-C6H3NCMe)2CH}]-
OTf (5-Os). The title compound was isolated as a light orange solid
(43 mg, 41%), following a procedure identical with that reported for
the corresponding Ru(II) complex.25 Anal. Found (calcd): C, 46.95
(47.99); H, 4.50 (4.70); N, 3.75 (3.73). Elemental analysis was
affected by the partial loss of ethylene. ESI MS+ (25 °C, CH2Cl2) (m/
z): 577.6035 [parent (M − C2H4 + H+)+, 100%, 577.2163]. 1H NMR
(25 °C, 400 MHz, CD2Cl2): δ (ppm): 1.35 (m, 2H, Os−CH2), 1.96
(s, 6H, o-CH3), 2.05 (s, 6H, α-CH3), 2.23 (s, 6H, o-CH3′), 2.35 (m,
2H, Os−CβH2), 4.54 (s, 1H, β-H), 4.67 (s, 6H, η6-C6H6), 7.10−7.13
(m, 2H, Ar p-CH), 7.16−7.18 (m, 2H, Ar m-CH), 7.22−7.24 (m, m-
CH′). 13C{1H} NMR (25 °C, 100 MHz, CD2Cl2): δ (ppm) −7.5 (s,
Os-CαH2), 16.9 (s, Os-CβH2), 18.0 (s, o-CH3), 18.9 (s, o-CH3′), 22.7
1
575.201]. H NMR (400 MHz, 25 °C CD2Cl2): δ (ppm) 2.13 (s, 12
H, o-CH3), 2.23 (s, 6H, α-CH3), 5.79 (s, 6H, η6-C6H6), 7.00 (s, 1H, β-
CH), 7.18−7.22 (m, 2H, Ar p-CH), 7.33−7.35 (m, 4H, m-CH).
13C{1H} NMR (101 MHz, 25 °C, CD2Cl2): δ (ppm) 19.1 (s, Ar o-
CH3), 23.2 (s, α-CH3), 77.1 (s, η6-C6H6), 107.9 (s, β-CH), 121.6 (q,
1
(s, α-CH3), 61.4 (s, β-CH), 80.1 (s, η6-C6H6), 121.6 (q, JCF = 321.5
−
−
1JCF = 320.9 Hz, CF3SO3 ), 128.3 (s, Ar p-CH), 129.2 (s, Ar m-CH),
Hz, CF3SO3 ), 128.1 (s, Ar p-CH), 128.9 (s, Ar o-C), 129.4 (s, Ar m-
130.0 (s, Ar o-C), 158.6 (s, Ar i-C), 165.7 (s, CN). 19F NMR (376
CH), 129.6 (s, Ar o-C′), 129.7 (s, Ar m-CH′), 152.8 (s, Ar i-C), 180.0
(s, CN). FT-IR (25 °C, ATR): ν (cm−1) 2955 (vw), 2917 (vw),
1626 (vw), 1612 (w), 1590 (vw), 1471 (w), 1420 (w), 1398 (w), 1381
(w), 1333 (vw), 1260 (vs), 1223 (m), 1183 (w), 1150 (s), 1132 (m),
1098 (w), 1028 (vs), 998 (vw), 883 (vw), 832 (m), 804 (w), 791 (w),
782 (w), 774 (m), 766 (m), 753 (w), 718 (w), 711 (vw).
−
MHz, 25 °C, CD2Cl2): δ (ppm) −78.89 (s, CF3SO3 ). FT-IR (25 °C,
ATR): ν (cm−1) 3068 (vw), 2919 (vw), 1592 (w), 1560 (w), 1512
(w), 1470 (w), 1430 (w), 1382 (w), 1345 (w), 1271 (vs, S−O), 1221
(m), 1180 (w), 1152 (s, C−F), 1098 (w, C−F), 1088 (w), 1029 (s),
979 (w), 876 (w), 863 (m), 778 (m), 752 (w), 716 (w).
Synthesis of [(η6-C6H6)-Os(CNXyl){(2,6-Me2-C6H3NCMe)2CH}]-
OTf (6-Os). 2-Os (100 mg, 0.138 mmol) and 2,6-dimethylphenyl
isocyanide (19 mg, 0.145 mmol) were weighed into a 50 mL Schlenk
tube under inert conditions and dissolved in dried and N2-saturated
CH2Cl2 (10 mL). The reaction mixture was stirred overnight under N2
and the solvent removed under vacuum to afford 6-Os as a red solid
(108 mg, 92%). Crystals suitable for X-ray analysis were grown from a
concentrated CH2Cl2 solution by slow vapor diffusion of n-pentane at
−10 °C. Anal. Found (calcd): C, 51.43 (51.92); H, 5.13 (4.71); N,
4.47 (4.91). ESI MS+ (25 °C, CH2Cl2) (m/z): 707.6621 [parent (M +
H+)+, 100%, 707.3000]. 1H NMR (400 MHz, 25 °C, CD2Cl2): δ
(ppm) 1.58 (s, 6H, α-CH3), 2.22 (s, 6H, Ar o-CH3), 2.26 (s, 6H, Ar o′-
CH3), 2.56 (s, 6H, Xyl Ar o-CH3), 4.85 (s, 6H, η6-C6H6), 5.13 (s, 1H,
β-CH), 7.06−7.34 (m, 9H, Ar CH). 13C{1H} NMR (100 MHz, 25 °C,
CD2Cl2): δ (ppm) 18.5 (s, Ar o-CH3), 19.6 (s, Xyl o-CH3), 19.7 (s, Ar
o′-CH3), 22.4 (s, α-CH3), 86.2 (s, η6-C6H6), 103.5 (s, β-CH), 121.6 (q,
Synthesis of [(η6-C6H6)OsCl{(2,6-Me2-C6H3NCMe)2CH2}]OTf
(3-Os). 2-Os (100 mg, 0.138 mmol) was suspended in dried and
N2-saturated Et2O (10 mL) in a 50 mL Schlenk tube under inert
conditions and cooled to −20 °C in a N2(l)/EtOH slurry. A 1 N
solution of Et2O/HCl (0.15 mL, 0.15 mmol) was added dropwise by
syringe with stirring. The reaction was warmed to room temperature
and stirred for 2 h under N2. The crude product was filtered under
inert conditions and washed with Et2O to afford 3-Os (97.6 mg, 93%)
as a light green solid. Crystals suitable for X-ray analysis were grown by
diffusion of n-pentane into a saturated solution of the title compound
in CH2Cl2. Anal. Found (calcd): C, 44.72 (44.29); H, 4.64 (4.25); N,
3.26 (3.69). ESI MS+ (25 °C, MeCN) (m/z): 575.2101 [parent (M −
Cl)+, 100%, 575.2102]. 1H NMR (400 MHz, 25 °C, CDCl3): δ (ppm)
2.14 (s, 6H, α-CH3), 2.31 (s, 6H, o-CH3), 2.34 (s, 6H, o-CH3′), 4.31
2
(d, 1H, JHH = 20.2 Hz, β-CH), 4.81 (d, 2JHH = 20.2 Hz, 1H, β-CH′),
5.05 (s, 6H, η6-C6H6), 7.10−7.14 (m, 2H, Ar p-CH), 7.19−7.22 (m,
4H, Ar m-CH). 13C{1H} NMR (101 MHz, 25 °C, CDCl3): δ (ppm)
18.7 (s, o-CH3), 19.0 (s, o-CH3′), 24.8 (s, α-CH3), 49.2 (s, β-CH2),
79.9 (s, η6-C6H6), 128.3 (s, Ar p-CH), 129.2(6) (s, Ar m-CH),
129.2(9) (s, Ar m-CH′), 129.8 (s, Ar o-CH), 130.2 (Ar o-CH′), 153.0
(Ar i-C), 183.0 (CN). 19F NMR (376 MHz, 25 °C, CDCl3): δ
−
1JCF = 321.5 Hz, CF3SO3 ), 127.4 (s, Xyl p-CH), 129.1 (s, Xyl Ar m-
CH), 129.7 (s, Ar m-CH), 129.8 (s, Ar p-CH), 130.4 (s, Xyl Ar o-CH),
131.6 (s, Ar o′-CH), 132.8 (s, Ar o-C), 136.6 (s, Xyl Ar i-CH), 154.7 (s,
Ar i-C), 164.2 (s, NCCH3). FT-IR (25 °C, ATR): ν (cm−1) 3062
(w), 2953 (w), 2920 (w), 2144 (s, CN), 1552 (w), 1523 (w), 1453
(m), 1435 (m), 1387 (s), 1263 (vs), 1225 (m), 1187 (m), 1168 (w),
1148 (m), 1134 (m), 1101 (vw), 1027 (vs), 975 (vw), 858 (vw), 839
(m), 808 (vw), 770 (s), 754 (w), 713 (w), 669 (w).
Hydrogenation Catalysis. The alkene substrates were distilled
from CaH2 and degassed with three freeze−thaw cycles prior to use.
The experiments were conducted in a custom-built multicell (10 mL
each) steel autoclave reactor. A THF stock solution (2 mL) containing
a magnetic Teflon stirrer and 0.1 mol % of 1-Os/Ru or 2-Os/Ru along
with the appropriate alkene (1.0 g) and dried (CaH2) and degassed n-
octane (100 mg) as a GC standard were added to the autoclave under
inert conditions. After the autoclave was sealed, the cells were purged
with high-purity H2 gas (99.8%, 5 bar). The autoclave was heated to
the required temperature (80 °C) under H2 pressure (10 bar). After
−
(ppm) −78.25 (s, CF3SO3 ). FT-IR (25 °C, Nujol mull, KBr disks), ν
(cm−1) 2953 (s), 2898 (s), 2861 (s), 1641 (w), 1463 (m), 1375 (m),
1267 (vs), 1229 (w), 1155 (s), 1099 (vw), 1030 (m), 910 (vw), 853
(w), 776 (w), 720 (vw), 637 (m).
Synthesis of [(η6-C6H6)OsH{(2,6-Me2-C6H3NCMe)2CH2}]OTf (4-
Os). 2-Os (120 mg, 0.17 mmol) was weighed into a narrow 20 mL
Schlenk tube under inert conditions and dissolved in dried and N2-
saturated THF (10 mL). The solution was degassed under slight
vacuum, and H2(g) was run over the solution for 2 min and allowed to
diffuse into the THF solution at −10 °C for 48 h to afford orange
crystals suitable for X-ray analysis. Elemental analysis was affected by
partial loss of hydrogen. Anal. Found (calcd): C, 45.98 (46.40); H,
1
4.33 (4.59); N, 3.78 (3.87). H NMR (400 MHz, 25 °C, CD2Cl2): δ
7354
dx.doi.org/10.1021/om400875r | Organometallics 2013, 32, 7345−7356